Author

K. W. Slayden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

J. E. Cummings· 1 shared R. A. Slayden· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

J. E. Cummings

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TPR1, a novel rifampin derivative demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A Priority Pathogen F. tularensis

J. E. Cummings, K. W. Slayden, R. A. Slayden

This study evaluates the efficacy of TPR1, a rifampin derivative, against F. tularensis both alone and in combination with doxycycline, showing reduced bacterial burden and 100% survival in mice.

bioRxiv · Feb 12, 2021Microbiology